Dosilicon Co., Ltd.

SSE:688110.SS

32.75 (CNY) • At close May 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 142.254193.959180.625159.971106.242159.388131.491115.806123.836198.266233.998369.276344.461349.176330.37266.364188.372192.887279.598151.687160.136
Cost of Revenue 122.094168.725151.905146.62893.4146.414121.593106.118103.002133.415163.166211.844172.53174.417181.938176.995133.783150.704217.76300
Gross Profit 20.1625.23428.71913.34312.84312.9749.8979.68820.83464.85170.832157.432171.931174.759148.43289.36954.58942.18361.835151.687160.136
Gross Profit Ratio 0.1420.130.1590.0830.1210.0810.0750.0840.1680.3270.3030.4260.4990.50.4490.3360.290.2190.22111
Reseach & Development Expenses 55.94455.25652.20648.09548.87246.35443.04248.19235.54426.39428.85532.6622.41127.42616.17415.81715.39611.79711.85300
General & Administrative Expenses 20.595-32.10443.983-6.91417.148-33.93740.001-8.64916.321-31.63737.939-6.91413.9027.094-15.15210.56311.3112.233-14.67600
Selling & Marketing Expenses 4.503-11.60214.4975.7555.5060.9387.3184.56.4182.6774.8393.9183.552-1.7525.8743.9124.1165.7915.21100
SG&A 25.098-43.70658.4823.71622.65415.60147.319-4.14922.738-28.96142.778-2.99517.4545.342-9.27917.65214.4498.025-9.46500
Other Expenses 4.8946.38-38.531-5.75-0.1-125.0170.397-0.38-0.5845.271-28.47923.532-0.036-0.74-0.71-211.051-154.6980.017-4.873-161.303-156.227
Operating Expenses 85.93257.92972.15477.56170.574186.97365.90466.74257.70242.70443.15453.19739.82947.64337.462-211.051-154.69830.32127.782-161.303-156.227
Operating Income -65.772-32.695-43.348-64.218-46.988-173.999-71.43-79.216-35.427-98.90765.549130.504141.215109.089104.0955.31233.6741.07520.706-9.6163.909
Operating Income Ratio -0.462-0.169-0.24-0.401-0.442-1.092-0.543-0.684-0.286-0.4990.280.3530.410.3120.3150.2080.1790.0060.074-0.0630.024
Total Other Income Expenses Net -0.002-0.2650.22918.033-0.18.4580.0170-0.078-1.6060.184-0.007-0.001-0.740.0020.085-0.1920.0170-0.0210.03
Income Before Tax -65.774-32.96-43.119-46.186-47.088-165.541-71.413-79.216-35.505-100.51365.732130.497141.213108.349104.09255.39833.4821.09220.707-9.6373.939
Income Before Tax Ratio -0.462-0.17-0.239-0.289-0.443-1.039-0.543-0.684-0.287-0.5070.2810.3530.410.310.3150.2080.1780.0060.074-0.0640.025
Income Tax Expense -2.3945.7590.273-1.3231.161-7.213-1.728-41.144-1.047-8.974-1.18810.7219.0137.0982.208157.064-155.9621.4710.388130.364-154.314
Net Income -59.242-36.801-39.22-46.617-44.505-159.951-71.192-40.74-34.459-91.53956.443104.543110.11693.69588.2145.14634.7453.1117.948-3.552.026
Net Income Ratio -0.416-0.19-0.217-0.291-0.419-1.004-0.541-0.352-0.278-0.4620.2410.2830.320.2680.2670.1690.1840.0160.064-0.0230.013
EPS -0.14-0.084-0.09-0.11-0.1-0.36-0.16-0.092-0.078-0.210.130.240.250.230.270.140.10.010.057-0.0110.006
EPS Diluted -0.14-0.084-0.09-0.11-0.1-0.36-0.16-0.092-0.078-0.210.130.240.250.230.270.140.10.010.057-0.0110.006
EBITDA -65.363-32.386-42.448-52.169-34.457-153.493-40.289-68.064-34.056-90.19775.584131.257141.672108.563107.879-98.48234.0291.98926.039-162.536160.136
EBITDA Ratio -0.459-0.167-0.235-0.326-0.324-0.963-0.306-0.588-0.275-0.4550.3230.3550.4110.3110.327-0.370.1810.010.093-1.0721